BOSTON (AP) - Boston Scientific Corp., a medical device maker, reported a loss of $269 million US for the third quarter Friday, a result largely blamed on a $598-million legal settlement but also tied to declining sales of its coronary stents.
http://c.moreover.com/click/here.pl?r406632584
http://c.moreover.com/click/here.pl?r406632584